Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention
Authors:
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Double Versus Standard Loading Dose of TicagrelorJACC, 2013
- Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial InfarctionCirculation: Cardiovascular Interventions, 2012
- Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trialsJournal of Thrombosis and Thrombolysis, 2012
- Prasugrel Versus Tirofiban Bolus With or Without Short Post-Bolus Infusion With or Without Concomitant Prasugrel Administration in Patients With Myocardial Infarction Undergoing Coronary StentingJACC: Cardiovascular Interventions, 2012
- Crushed Clopidogrel Administered via Nasogastric Tube Has Faster and Greater Absorption than Oral Whole TabletsJournal of Interventional Cardiology, 2009
- Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trialEuropean Heart Journal, 2009
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialThe Lancet, 2009
- Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarctionThrombosis Research, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Determination of the active and inactive metabolites of prasugrel in human plasma by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006